Invention Grant
- Patent Title: Prodrugs activated by caspase
-
Application No.: US15690157Application Date: 2017-08-29
-
Publication No.: US10357572B2Publication Date: 2019-07-23
- Inventor: Sang-Yoon Kim , Youngro Byun , Seung Woo Chung
- Applicant: Pharosgen Co., Ltd.
- Applicant Address: KR Seoul
- Assignee: PHAROSGEN CO., LTD.
- Current Assignee: PHAROSGEN CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Foley & Lardner LLP
- Priority: KR10-2014-0162555 20141120
- Main IPC: A61N1/40
- IPC: A61N1/40 ; A61N5/06 ; A61N7/00 ; A61N7/02 ; A61B18/02 ; A61K31/65 ; A61K38/14 ; A61K45/06 ; A61K47/54 ; A61K47/55 ; A61K47/60 ; A61K47/61 ; A61K47/64 ; A61K47/65 ; A61N5/067 ; A61K31/337
Abstract:
Described are prodrug conjugates that release a chemotherapeutic agent upon activation by caspase, and methods using such prodrug conjugates to induce apoptosis, amplify apoptosis, and treat cancer.
Public/Granted literature
- US20180185498A1 PRODRUGS ACTIVATED BY CASPASE Public/Granted day:2018-07-05
Information query
